JP Morgan Maintains Overweight on US Physical Therapy, Lowers Price Target to $110
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
JP Morgan analyst Calvin Sternick maintains US Physical Therapy (NYSE:USPH) with a Overweight and lowers the price target from $120 to $110.
JP Morgan analyst Calvin Sternick maintains US Physical Therapy (NYSE:USPH) with a Overweight and lowers the price target from $120 to $110.